fusarium has been researched along with Disease Models, Animal in 66 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (9.09) | 18.7374 |
| 1990's | 9 (13.64) | 18.2507 |
| 2000's | 11 (16.67) | 29.6817 |
| 2010's | 34 (51.52) | 24.3611 |
| 2020's | 6 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, J; Huang, L; Lin, Y; Tang, H | 1 |
| Aparicio-Ozores, G; Bautista-de Lucio, VM; Bautista-Hernández, LA; Calvillo-Medina, RP; Castro-Tecorral, FI; López-Villegas, EO; Ponce-Angulo, DG; Ribas-Aparicio, RM | 1 |
| Abd Eldaim, MA; Abdallah, AEM; Abdel-Daim, MM; Abdelaziz, SAM; Abdul Rashid, S; Abdullah, AS; Abdullah, LC; Abramson, MJ; Ahmed, HB; Ahmed, MM; Ahn, YC; Alexander, DC; Ando, T; Angelone, AM; Anglani, F; Ap, Y; Arthanari, SK; Axelrad, C; Bai, S; Bakonyi, P; Barnes, E; Beckmann, NA; Bélafi-Bakó, K; Bennett, CM; Bestha, RM; Bitsch, RG; Bradley, CA; Bu, Y; Calò, LA; Cañedo-Villaroya, E; Carlson, L; Caruso, S; Casado-Flores, J; Ceol, M; Cesarino, I; Chen, IL; Chen, R; Chen, X; Chilvers, MI; Cho, WK; Choong, TSY; Conceição-Neto, N; Culver, EL; Dai, X; de Lama Caro-Patón, G; De Rosa, I; Del Prete, D; Dharmage, SC; Dimitriadis, E; Dittakavi, S; Dobrowolski, JC; Edin, S; Elgarawany, GE; Emam, HE; Emmens, RW; Erbas, B; Erwich, JJHM; Farghali, M; Feng, L; Funston, RN; Gabler, NK; Gale, P; Ganesh, M; Gao, J; Gao, L; Gao, X; García-Salido, A; Gatto, R; Gautam, S; Ge, C; Ghogomu, SM; Gianesello, L; Gonçales, VR; Gooch, JL; Gooding, JJ; Gourley, GG; Gu, H; Gu, X; Gu, Z; Guerreri, M; Guillén, M; Hazzaa, SM; Heylen, E; Hicks, R; Hong, X; Hoshi, M; Hu, B; Hu, LX; Hu, R; Hu, S; Huang, J; Huang, K; Hubbard, WB; Hui, J; Hwang, NY; Iannacci, J; Ianus, A; Iglesias-Bouzas, MI; Ihara, I; Iwasaki, M; Jaeger, S; Kandel, YR; Karpińska, G; Kim, HK; Klopfenstein, TJ; Knorr, D; Koók, L; Kotb, S; Kruithof, S; Larsson, P; Laurence, C; Leng, J; Li, H; Li, J; Li, Q; Li, S; Li, X; Li, Z; Lian, J; Liang, JX; Liang, X; Lighaam, LC; Lin, CW; Lin, HC; Lin, J; Ling, A; Liu, J; Liu, P; Liu, YS; Ljuslinder, I; Lo, GH; Lodge, CJ; Löfgren-Burström, A; Lowe, AJ; Lu, M; Lu, N; Lucero-Prisno, DE; Luebbe, KM; Luo, X; Ma, Z; Maes, P; Makuch, M; Malekbala, MR; Mao, Z; Martínez-Romera, I; Marzo, G; Mathew, FM; Mattei, A; Matthijnssens, J; Mayumi, M; Morita, N; Mueller, DS; Mullangi, R; Mummolo, S; Murthi, P; Myte, R; Nabeshima, T; Nakamoto, K; Nehdi, IA; Nemestóthy, N; Niessen, HWM; Noh, JM; Nota, A; Nunes, D; Oh, D; Öhlund, D; Olsen, KM; Ono, H; Osawa, Y; Palmqvist, R; Palombo, M; Park, M; Patience, JF; Peng, Y; Perng, DS; Persano, A; Priante, G; Prince, SJ; Pulipati, S; Pyo, H; Qiu, X; Quan, J; Quaranta, F; Quinzi, V; Rademacher, CJ; Rajaraman, G; Rashid, U; Rauch, JC; Rector, A; Remmerswaal, EBM; Ren, R; Rispens, T; Rocha, GS; Saad, NM; Saito, K; Salamova, A; Sarfaraz, K; Satoshi, A; Schnellmann, RG; Scholpa, NE; Schonhoff, M; Schwartz, KJ; Schwarze, M; Schweer, WP; Seiichi, Y; Serrano-González, A; Severino, J; Shemesh, N; Shi, ZQ; Shike, DW; Shim, YM; Siciliano, PA; Siebenrock, KA; Silva, MKL; Smith, DL; Soltani, S; Song, YM; Spry, ML; Stalker, LA; Stokes, RS; Sullivan, PG; Sun, JM; Sun, S; Svanes, C; Syo, K; Tai, CM; Takashima, S; Tashita, C; Taurino, A; Ten Berge, IJM; Tenuta, AU; Teo, SH; Tilley, RD; Trivedi, RK; Umetsu, K; Unger, PA; van Bruggen, R; van Ham, SM; Van Ranst, M; Vanitha, J; Vekaria, HJ; Venier, M; Venkateshwaran, K; Venkert, A; Vermeulen, E; Wan, C; Wang, H; Wang, N; Wang, P; Wang, T; Wang, X; Wang, Y; Wise, KA; Wolbink, GJ; Wu, J; Wu, P; Wu, S; Wu, Y; Xia, Q; Xin, W; Xiong, Q; Xu, H; Xu, P; Xue, S; Yamamoto, Y; Yamashiro, T; Yan, F; Yan, H; Yan, S; Yan, Y; Yang, JM; Yang, L; Yang, P; Ye, W; Yeh, JH; Yinda, CK; Ying, GG; Ying, L; Yoon, HG; Yu, H; Zainuddin, M; Zakkula, A; Zeller, M; Zeng, Y; Zha, J; Zhang, F; Zhang, H; Zhang, M; Zhang, Q; Zhang, S; Zhang, T; Zhang, Z; Zhao, C; Zhao, J; Zhao, Y; Zhong, Q; Zhu, J; Zingmark, C; Zo, JI; Zou, Y | 1 |
| Edwar, L; Janna, YM; Louisa, M; Rozaliyani, A | 1 |
| Hu, J; Lin, Y | 1 |
| Brown, ME; Fuller, KK; Kamath, MM; Karamichos, D; Liu, Y; Montgomery, ML; Nicholas, S | 1 |
| Hu, J; Huang, Y; Lin, J; Lin, Y | 1 |
| Dananjaya, SHS; De Zoysa, M; Edussuriya, M; Lee, J; Nikapitiya, C; Shin, SY; Udayangani, RMC | 1 |
| Bilgihan, K; Erdogan, M; Kalkanci, A; Karakurt, F; Ozdemir, HB; Yar Saglam, AS | 1 |
| Li, Z; Liu, S; Wang, L; Yue, J; Zhang, H; Zhu, Z | 1 |
| Clark, HL; de Jesus, T; Ghannoum, MG; Minns, MS; Pearlman, E; Sun, Y | 1 |
| Bilgihan, K; Erdoğan, M; Hizel, K; Kalkanci, A; Karakus, AK; Ozdemir, HB; Seker, T; Tum, AE; Unal, EA; Yesilirmak, N | 1 |
| Capilla, J; Celis, A; Guarro, J; Guevara-Suarez, M; Navarro-Rodríguez, P; Paredes, K | 1 |
| Alexandrino Becker, TC; Costa, MI; Jarros, IC; Kischkel, B; Negri, M; Svidzinski, TIE; Veiga, FF; Vilugron Rodrigues, FA | 1 |
| Böhm, J; Yunus, AW | 1 |
| Chen, G; Deng, X; He, S; Li, Z; Liu, H; Liu, S; Wang, L; Xie, Y; Yang, B; Zhang, H; Zhang, J; Zhao, H | 1 |
| Ceceñas, LA; Garza-González, E; Gerardo González, J; González, GM; Márquez, J; Palma-Nicolás, JP; Treviño-Rangel, Rde J | 1 |
| Abou Shousha, M; Alfonso, EC; Bajenaru, ML; Dubovy, SR; Echegaray, JJ; Iovieno, A; Maestre-Mesa, J; Miller, D; Oechsler, RA; Perez, VL; Ruggeri, M; Santos, AR | 1 |
| Di Pietro, A; Gow, NA; MacCallum, D; Schäfer, K | 1 |
| Kamei, K; Matsuzawa, T; Mikami, Y; Moretti, ML; Muraosa, Y; Schreiber, AZ; Taguchi, H; Trabasso, P | 1 |
| Buelow, DR; Gu, Z; Hayden, RT; Petraitiene, R; Petraitis, V; Walsh, TJ | 1 |
| Carai, P; Emmens, RW; Heymans, S; Krijnen, PA; Murk, JL; Niessen, HW; Papageorgiou, A; Paulus, WJ; Rozendaal, L; Seven-Deniz, S; Smit, S; van Ham, MS; van Rossum, AC; Woudstra, L; Wouters, D; Zeerleder, S | 1 |
| Chen, S; Dong, C; Han, X; Hu, J; Hu, Y; Li, Y; Xu, G; Yang, J; Zhang, J; Zhu, X | 1 |
| Escrivá, L; Font, G; Manyes, L | 1 |
| Fang, X; Geng, S; Li, Y; Wang, Y; Yang, X; Zhou, X | 1 |
| Hu, J; Wang, Y; Xie, L | 1 |
| da Cruz Fernandes, M; Hernandes, L; Marangon, AV; Meurer, R; Salci, TP; Svidzinski, TI | 1 |
| Chandra, J; Ghannoum, MA; Mukherjee, P; Pearlman, E; Sun, Y; Szczotka-Flynn, L | 1 |
| Bocanegra, R; Graybill, JR; Najvar, LK; Patterson, TF; Wiederhold, NP | 1 |
| Pestka, JJ | 1 |
| Capilla, J; Guarro, J; Pastor, FJ; Ruíz-Cendoya, M | 1 |
| Bernal-Martínez, L; Buitrago, MJ; Castelli, MV; Cuenca-Estrella, M; Rodríguez-Tudela, JL | 1 |
| Di Pietro, A; Navarro-Velasco, GY; Ortíz-Urquiza, A; Prados-Rosales, RC; Quesada-Moraga, E | 1 |
| Berra, A; Berra, M; Boscaro, G; Galperin, G; Tau, J; Zarate, J | 1 |
| Coleman, JJ; Kasperkovitz, PV; Muhammed, M; Mylonakis, E; Vyas, JM | 1 |
| Breger, J; Coleman, JJ; Fuchs, BB; Muhammed, M; Mylonakis, E; Wu, MP | 1 |
| Leal, SM; Pearlman, E | 1 |
| Wu, B; Xu, J | 1 |
| Boeira, SP; Del'Fabbro, L; Filho, CB; Furian, AF; Jessé, CR; Oliveira, MS; Royes, LF | 1 |
| Chandra, J; Ghannoum, MA; Mukherjee, PK; Pearlman, E; Sun, Y; Yu, C | 1 |
| Gu, L; Gu, Y; Guo, W; Ke, Y; Shen, Y; Sun, Y; Tan, R; Wu, L; Wu, X; Xu, Q; Xu, S | 1 |
| Domijan, AM | 1 |
| Bocanegra, R; Gonzalez, GM; Graybill, JR; Hernandez, S; Najvar, LK | 1 |
| Kumagai, S; Reiss, E; Sugita-Konishi, Y; Sugiura, Y | 1 |
| Keasler, VV; Mitchell, BM; Wilhelmus, KR; Wu, TG | 1 |
| Chamilos, G; Kontoyiannis, DP; Lewis, RE; Lionakis, MS; Raad, II; Samonis, G; Wiederhold, NP | 1 |
| Brandle, J; Du, C; Jevnikar, AM; Ma, S; Menassa, R; Poussier, P; Yin, ZQ | 1 |
| Chong, EM; Mitchell, BM; Pate, JC; Wilhelmus, KR; Wu, TG | 1 |
| Cetinkaya, Z; Ermis, SS; Inan, UU; Kiraz, N; Kusbeci, T; Ozturk, F; Yavas, GF | 2 |
| Chandler, JW; Fiscella, RG; Messick, CR; Moshifar, M; Pendland, SL; Viana, M | 1 |
| Bartlett, MS; Espinel-Ingroff, A; Ghannoum, MA; Lancaster, MV; Odds, FC; Pfaller, MA; Rex, JH; Rinaldi, MG; Van Gerven, F; Walsh, TJ | 1 |
| Otori, N; Paydas, G; Stierna, P; Westrin, KM | 1 |
| Guarro, J; Mayayo, E; Pujol, I | 1 |
| Abel, S; Gelderblom, WC; Lemmer, ER; Marasas, WF; Marnewick, J; Ramljak, D; Smuts, CM | 1 |
| Akrabawi, PL; Clayton, Y; Jones, BR; O'Day, DM; Richmond, LD | 1 |
| Akrabawi, PL; Head, WS; O'Day, DM; Ratner, HB | 1 |
| Ishibashi, Y | 1 |
| Forster, RK; Rebell, G | 1 |
| Munday, KA; Taylor, TG; Tuner, MR; Winocour, PD | 1 |
| Anaissie, EJ; Bodey, GP; Hachem, R; Legenne, P; Legrand, C; Nelson, P | 1 |
| Head, WS; O'Day, DM; Ray, WA; Robinson, RD; Williams, TE | 1 |
| Anaissie, E; Bodey, GP; Hashem, R; Legrand, C; Nelson, P; Ro, J | 1 |
| Dick, JD; Gilbert, ML; Goodman, DF; Gottsch, JD; Stark, WJ; Sulewski, ME | 1 |
| Anaissie, EJ; Rinaldi, MG | 1 |
| Burmeister, HR; Hamilton, PB; Weeks, BA; Wyatt, RD | 1 |
6 review(s) available for fusarium and Disease Models, Animal
| Article | Year |
|---|---|
Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Amylose; Anaerobiosis; Animals; Anti-Bacterial Agents; Anura; Arginase; Arthritis, Rheumatoid; Asthma; Atmosphere; B-Lymphocytes; Basic Helix-Loop-Helix Transcription Factors; Bioelectric Energy Sources; Biofilms; Biofuels; Biomarkers; Biopolymers; Bioreactors; Brain; Brain Injuries, Traumatic; Breast Neoplasms; Calibration; Carbon Tetrachloride; Caspase 3; Catalysis; Catechin; Cations; Cattle; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Body; Cell Line, Tumor; Cell Plasticity; Chemical and Drug Induced Liver Injury; Chemistry Techniques, Synthetic; China; Chitosan; Chloride Channels; Chromatography, High Pressure Liquid; Chromosome Mapping; Cognition; Cognitive Dysfunction; Cohort Studies; Colitis, Ulcerative; Colloids; Coloring Agents; Congresses as Topic; Correlation of Data; Crystallization; Cyanoacrylates; Cyclohexane Monoterpenes; Cyprinidae; Cytochrome P-450 CYP1A1; Death, Sudden; Dent Disease; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Disease Progression; Disease Resistance; Disulfides; Drug Monitoring; Drug Stability; Ecotoxicology; Electricity; Electrodes; Endocytosis; Environmental Exposure; Environmental Monitoring; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Esophageal and Gastric Varices; Esters; Fagopyrum; Female; Ferrosoferric Oxide; Flame Retardants; Flavobacteriaceae; Flow Cytometry; Follow-Up Studies; Formoterol Fumarate; Fusarium; Garlic; Gastrointestinal Hemorrhage; Gene Expression; Genes, Plant; Genetic Markers; Glial Fibrillary Acidic Protein; Gliosis; Global Health; Glutathione Transferase; Glycine max; Gum Arabic; Hemostasis, Endoscopic; Hepatocytes; Hippocampus; Humans; Hydrogen-Ion Concentration; Illinois; Immunoglobulin G; Indoleamine-Pyrrole 2,3,-Dioxygenase; Infant, Newborn; Infant, Small for Gestational Age; Injections, Intraperitoneal; Interleukin-4; Iowa; Iron; Ki-67 Antigen; Kidney; Kinetics; Kynurenine; Lakes; Levofloxacin; Lipid Peroxidation; Lipids; Liver; Liver Cirrhosis, Experimental; Magnetic Fields; Magnetic Iron Oxide Nanoparticles; Male; Manure; Maze Learning; Memory, Short-Term; Metal Nanoparticles; Metals, Heavy; Methane; Mice; Mice, Inbred C57BL; Mice, Knockout; Michigan; Microalgae; Microbial Consortia; Mitochondria; Models, Animal; Models, Chemical; Models, Neurological; Molecular Structure; Molecular Weight; Mutation; Myeloid-Derived Suppressor Cells; NADPH Oxidase 2; Neoplasm Recurrence, Local; Neurites; Neurons; Neuroprotective Agents; NF-kappa B; NIH 3T3 Cells; Nitric Oxide Synthase Type II; Nitrogen; Ohio; Ointments; Ontario; Organelle Biogenesis; Organophosphates; Organophosphorus Compounds; Oxidative Stress; Palladium; Particle Size; Pectins; Phenotype; Phytotherapy; Piperidines; Placenta; Plant Diseases; Plant Extracts; Polymers; Polymorphism, Genetic; Polyphenols; Powders; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Protein Kinase Inhibitors; Protein Structure, Secondary; Proteins; Pyridines; Pyrimidines; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Aryl Hydrocarbon; Receptors, Chemokine; Receptors, Formyl Peptide; Receptors, Lipoxin; Recovery of Function; Recurrence; Reference Standards; Reference Values; Reproducibility of Results; Respiratory Function Tests; Retrospective Studies; Risk; Sensitivity and Specificity; Sewage; Signal Transduction; Sodium Glutamate; Soil; Solanum tuberosum; Solubility; Solutions; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spermatozoa; STAT3 Transcription Factor; Sulfamethoxazole; Tea; Temperature; Thermodynamics; Thrombin; Treatment Outcome; Triazoles; United States; Viscosity; Waste Disposal, Fluid; Wastewater; Water; Water Pollutants, Chemical; Water Purification; White Matter; Wisconsin; X-Ray Diffraction; Zea mays | 2013 |
In vivo toxicity studies of fusarium mycotoxins in the last decade: a review.
Topics: Animal Feed; Animals; Chickens; Consumer Product Safety; Disease Models, Animal; Food Contamination; Food Microbiology; Fumonisins; Fusarium; Mice; Mycotoxins; Rats; Swine; T-2 Toxin; Trichothecenes; Zearalenone | 2015 |
Deoxynivalenol: mechanisms of action, human exposure, and toxicological relevance.
Topics: Animals; Disease Models, Animal; Edible Grain; Environmental Exposure; Food Microbiology; Fusarium; Gastroenteritis; Gastrointestinal Tract; Humans; Male; Mice; Ribosomes; Risk Assessment; Signal Transduction; Swine; Translational Research, Biomedical; Trichothecenes | 2010 |
The role of cytokines and pathogen recognition molecules in fungal keratitis - Insights from human disease and animal models.
Topics: Animals; Contact Lenses; Cornea; Cytokines; Disease Models, Animal; Eye Infections, Fungal; Fusarium; Humans; Keratitis; Lectins, C-Type; Mice; Mycoses; Toll-Like Receptor 4 | 2012 |
Fumonisin B(1): a neurotoxic mycotoxin.
Topics: Animals; Carcinogens; Cell Culture Techniques; Disease Models, Animal; Esophageal Neoplasms; Food Contamination; Food Microbiology; Fumonisins; Fusarium; Humans; Leukoencephalopathies; Liver Neoplasms; Neural Tube Defects; Neurotoxins; Neurotransmitter Agents; Pulmonary Edema; Zea mays | 2012 |
Fumonisin-induced hepatocarcinogenesis: mechanisms related to cancer initiation and promotion.
Topics: Animal Nutritional Physiological Phenomena; Animals; Body Weight; Carboxylic Acids; Carcinogens, Environmental; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Fumonisins; Fusarium; Lipids; Liver Neoplasms, Experimental; Male; Mycotoxins; Phospholipids; Rats | 2001 |
1 trial(s) available for fusarium and Disease Models, Animal
60 other study(ies) available for fusarium and Disease Models, Animal
| Article | Year |
|---|---|
MiR-223-3p Regulates Autophagy and Inflammation by Targeting ATG16L1 in Fusarium solani-Induced Keratitis.
Topics: Animals; Autophagy; Cells, Cultured; Disease Models, Animal; Eye Infections, Fungal; Fusarium; Gene Expression Regulation; Keratitis; Mice; Mice, Inbred BALB C; MicroRNAs; RNA | 2022 |
Microscopic characterization of biofilm in mixed keratitis in a novel murine model.
Topics: Animals; Biofilms; Coinfection; Cornea; Disease Models, Animal; Female; Fusarium; Humans; Immunocompromised Host; Keratitis; Mice; Mice, Inbred BALB C; Staphylococcus aureus | 2020 |
Therapeutic response time of topical voriconazole 1% and intrastromal voriconazole 0.05% versus topical natamycin 5% monotherapy in Fusarium keratitis in rabbit.
Topics: Administration, Topical; Animals; Antifungal Agents; Cornea; Corneal Ulcer; Disease Models, Animal; Eye Infections, Fungal; Fusariosis; Fusarium; Humans; Keratitis; Natamycin; Rabbits; Voriconazole | 2020 |
Fusarium infection alters the m
Topics: Adenosine; Animals; Cornea; Disease Models, Animal; Eye Infections, Fungal; Fusariosis; Fusarium; Gene Expression Regulation; Keratitis; Male; Mice; Mice, Inbred BALB C; RNA Caps; RNA, Messenger; Up-Regulation | 2020 |
A novel 3D culture model of fungal keratitis to explore host-pathogen interactions within the stromal environment.
Topics: Animals; Aspergillosis; Aspergillus fumigatus; Cell Culture Techniques; Corneal Keratocytes; Corneal Stroma; Corneal Ulcer; Cytokines; Disease Models, Animal; Eye Infections, Fungal; Fusariosis; Fusarium; Host-Pathogen Interactions; Humans; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Real-Time Polymerase Chain Reaction | 2021 |
Inhibiting miR-129-5p alleviates inflammation and modulates autophagy by targeting ATG14 in fungal keratitis.
Topics: Animals; Antagomirs; Autophagy; Autophagy-Related Proteins; Beclin-1; Blotting, Western; Corneal Ulcer; Disease Models, Animal; Eye Infections, Fungal; Fusariosis; Fusarium; Inflammation; Lysosomes; Mice; Mice, Inbred BALB C; MicroRNAs; Microscopy, Fluorescence; Microtubule-Associated Proteins; Real-Time Polymerase Chain Reaction; Vesicular Transport Proteins | 2021 |
In vitro and in vivo antifungal efficacy of plant based lawsone against Fusarium oxysporum species complex.
Topics: Animals; Antifungal Agents; Autophagy; Cell Membrane; Cell Membrane Permeability; Cell Wall; Disease Models, Animal; Fish Diseases; Fluoresceins; Fusarium; Gene Expression Regulation, Fungal; Genes, Fungal; Hyphae; In Vitro Techniques; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Confocal; Microscopy, Electron, Scanning; Muscles; Naphthoquinones; Pest Control, Biological; Plant Diseases; Plant Extracts; Propidium; Reactive Oxygen Species; RNA, Messenger; Spores, Fungal; Zebrafish | 2017 |
Corneal Cross-Linking Has No Effect on Matrix Metalloproteinase 9 and 13 Levels During Fungal Keratitis on the Early Stage.
Topics: Animals; Candida; Cornea; Cross-Linking Reagents; Disease Models, Animal; Fusarium; Gene Expression Profiling; Keratitis; Matrix Metalloproteinase 13; Matrix Metalloproteinase 9; Rabbits; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Treatment Outcome | 2018 |
Antimicrobial efficacy of corneal cross-linking in vitro and in vivo for Fusarium solani: a potential new treatment for fungal keratitis.
Topics: Animals; Anti-Infective Agents; Collagen; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Cross-Linking Reagents; Disease Models, Animal; Eye Infections, Fungal; Fusariosis; Fusarium; Male; Mice; Mice, Inbred C57BL; Photosensitizing Agents; Riboflavin; Ultraviolet Rays | 2018 |
Atovaquone Impairs Growth of Aspergillus and Fusarium Keratitis Isolates by Modulating Mitochondrial Function and Zinc Homeostasis.
Topics: Animals; Antifungal Agents; Aspergillus; Atovaquone; Disease Models, Animal; Epithelial Cells; Eye Infections, Fungal; Fusarium; Homeostasis; Hyphae; Keratitis; Mice; Mice, Inbred C57BL; Mitochondria; Zinc | 2018 |
Impact of Iontophoresis and PACK-CXL Corneal Concentrations of Antifungals in an In Vivo Model.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Collagen; Cornea; Cross-Linking Reagents; Disease Models, Animal; Eye Infections, Fungal; Fusariosis; Fusarium; Iontophoresis; Keratitis; Photochemotherapy; Rabbits; Ultraviolet Rays; Voriconazole | 2018 |
Lack of correlation of ECV and outcome in an in vivo murine model of systemic fusariosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Fusariosis; Fusarium; Mice; Voriconazole | 2018 |
Effects of intratracheal Fusarium solani inoculation in immunocompetent mice.
Topics: Animals; Colony Count, Microbial; Disease Models, Animal; Female; Fusariosis; Fusarium; Host-Pathogen Interactions; Immunocompromised Host; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Mycoses; Spores, Fungal; Survival Rate; Trachea | 2019 |
Serum cation profile of broilers at various stages of exposure to deoxynivalenol.
Topics: Animals; Cations; Disease Models, Animal; Fusarium; Male; Poisoning; Poultry Diseases; Serum; Time Factors; Trichothecenes | 2013 |
A novel murine model of Fusarium solani keratitis utilizing fluorescent labeled fungi.
Topics: Animals; Benzenesulfonates; Corneal Ulcer; Disease Models, Animal; Eye Infections, Fungal; Fluorescent Dyes; Fusariosis; Fusarium; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Staining and Labeling | 2013 |
Murine model of disseminated fusariosis: evaluation of the fungal burden by traditional CFU and quantitative PCR.
Topics: Animals; Colony Count, Microbial; Disease Models, Animal; Fusariosis; Fusarium; Kidney; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Real-Time Polymerase Chain Reaction; Spleen; Time Factors | 2013 |
A novel rat contact lens model for Fusarium keratitis.
Topics: Animals; Contact Lens Solutions; Contact Lenses; Disease Models, Animal; Eye Infections, Fungal; Female; Fusariosis; Fusarium; Humans; Keratitis; Rats; Rats, Sprague-Dawley; Tomography, Optical Coherence | 2013 |
Murine model for Fusarium oxysporum invasive fusariosis reveals organ-specific structures for dissemination and long-term persistence.
Topics: Animals; Colony Count, Microbial; Disease Models, Animal; Eye; Female; Fusariosis; Fusarium; Immunocompromised Host; Immunosuppressive Agents; Mice; Tail; Thrombosis | 2014 |
Development of cycling probe-based real-time PCR system to detect Fusarium species and Fusarium solani species complex (FSSC).
Topics: Animals; Disease Models, Animal; DNA Primers; Female; Fusariosis; Fusarium; Humans; Mice, Inbred ICR; Molecular Diagnostic Techniques; Mycology; Real-Time Polymerase Chain Reaction; Reproducibility of Results; RNA, Fungal; RNA, Ribosomal, 28S; Sensitivity and Specificity | 2014 |
Quantitative multiplexed detection of common pulmonary fungal pathogens by labeled primer polymerase chain reaction.
Topics: Animals; Aspergillus; Disease Models, Animal; Female; Fusarium; Genes, Fungal; Humans; Lung Diseases, Fungal; Molecular Diagnostic Techniques; Mucorales; Multiplex Polymerase Chain Reaction; Mycological Typing Techniques; Rabbits; Real-Time Polymerase Chain Reaction; RNA, Fungal; RNA, Ribosomal, 28S; RNA, Ribosomal, 5.8S; Scedosporium; Sensitivity and Specificity | 2014 |
Lymphocytes infiltrate the quadriceps muscle in lymphocytic myocarditis patients: a potential new diagnostic tool.
Topics: Animals; Cadaver; Depsipeptides; Diagnosis, Differential; Disease Models, Animal; Female; Follow-Up Studies; Fusarium; Humans; Immunohistochemistry; Lymphocyte Count; Lymphocytes; Mice; Mice, Inbred C3H; Myocarditis; Myocardium; Quadriceps Muscle; Retrospective Studies | 2014 |
Role of activated macrophages in experimental Fusarium solani keratitis.
Topics: Animals; Cornea; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Eye Infections, Fungal; Female; Flow Cytometry; Fusariosis; Fusarium; Immunity, Cellular; Immunohistochemistry; Keratitis; Macrophage Activation; Macrophages; Male; Mice; Mice, Inbred BALB C; Real-Time Polymerase Chain Reaction; RNA | 2014 |
Pathogenicity of Conidiobolus coronatus and Fusarium solani in mouse models.
Topics: Animals; Conidiobolus; Cyclophosphamide; Disease Models, Animal; Fusariosis; Fusarium; Immunocompromised Host; Immunosuppressive Agents; Lung; Male; Mice; Mice, Inbred ICR; Prednisolone; Skin; Zygomycosis | 2017 |
Potential role of macrophages in experimental keratomycosis.
Topics: Animals; Candida albicans; Candidiasis; Clodronic Acid; Colony Count, Microbial; Cytokines; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Eye Infections, Fungal; Female; Fluorescent Antibody Technique, Indirect; Fusarium; Keratitis; Liposomes; Macrophages; Male; Mice; Mice, Inbred BALB C; Mycoses; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Th1 Cells; Th2 Cells; Toll-Like Receptor 4 | 2009 |
Metabolic extract of Fusarium oxysporum induces histopathologic alterations and apoptosis in the skin of Wistar rats.
Topics: Animals; Apoptosis; Collagen Type I; Collagen Type III; Dermis; Disease Models, Animal; Fusarium; Humans; In Situ Nick-End Labeling; Injections, Intradermal; Male; Mast Cells; Mycoses; Mycotoxins; Rats; Rats, Wistar | 2009 |
A murine model of contact lens-associated fusarium keratitis.
Topics: Animals; Biofilms; Chemokine CXCL1; Colony Count, Microbial; Contact Lenses; Corneal Opacity; Corneal Ulcer; Cyclophosphamide; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Eye Infections, Fungal; Fusarium; Hydrogels; Immunity, Innate; Mice; Mice, Inbred C57BL; Mycoses; Myeloid Differentiation Factor 88; Receptors, Interleukin-1; Silicones; Toll-Like Receptor 4 | 2010 |
Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani.
Topics: Animals; Antifungal Agents; Chemoprevention; Disease Models, Animal; Drug Resistance, Fungal; Fusarium; Humans; Kidney; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycoses; Neutropenia; Treatment Outcome; Triazoles | 2010 |
Treatment of murine Fusarium verticillioides infection with liposomal amphotericin B plus terbinafine.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Fusarium; Kidney; Male; Mice; Mycoses; Naphthalenes; Spleen; Survival Analysis; Terbinafine; Treatment Outcome | 2011 |
Detection of invasive infection caused by Fusarium solani and non-Fusarium solani species using a duplex quantitative PCR-based assay in a murine model of fusariosis.
Topics: Animals; Disease Models, Animal; DNA, Fungal; Fusariosis; Fusarium; Male; Mice; Mice, Inbred ICR; Molecular Diagnostic Techniques; Multiplex Polymerase Chain Reaction; Mycology; Oligonucleotide Probes; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity; Serum | 2012 |
Galleria mellonella as model host for the trans-kingdom pathogen Fusarium oxysporum.
Topics: Animals; Disease Models, Animal; Fusariosis; Fusarium; Gene Knockout Techniques; Genes, Fungal; Green Fluorescent Proteins; Hemocytes; Kaplan-Meier Estimate; Mitogen-Activated Protein Kinases; Models, Biological; Moths; Mutation; Transcription Factors; Virulence | 2011 |
Treatment of fungal keratitis from Fusarium infection by corneal cross-linking.
Topics: Animals; Colony Count, Microbial; Disease Models, Animal; Eye Infections, Fungal; Fusariosis; Fusarium; Keratitis; Photosensitizing Agents; Rabbits; Riboflavin; Ultraviolet Therapy | 2012 |
Fusarium pathogenesis investigated using Galleria mellonella as a heterologous host.
Topics: Animals; Antifungal Agents; Disease Models, Animal; Fusariosis; Fusarium; Humans; Larva; Male; Mice; Moths; Virulence | 2011 |
The role of mycelium production and a MAPK-mediated immune response in the C. elegans-Fusarium model system.
Topics: Animals; Antifungal Agents; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Disease Models, Animal; Fusariosis; Fusarium; Host-Pathogen Interactions; Humans; Mitogen-Activated Protein Kinases; Mycelium; Signal Transduction | 2012 |
Antithrombotic effect of a novel protein from Fusarium sp. CPCC 480097 in a rat model of artery-vein bypass thrombosis.
Topics: Animals; Arteriovenous Shunt, Surgical; Disease Models, Animal; Fibrinolytic Agents; Fungal Proteins; Fusarium; Male; Rats; Rats, Sprague-Dawley; Thrombosis | 2012 |
Possible role for glutathione-S-transferase in the oligozoospermia elicited by acute zearalenone administration in Swiss albino mice.
Topics: Animals; Catalase; Disease Models, Animal; Down-Regulation; Estrogens, Non-Steroidal; Fusarium; Glutathione Transferase; Kidney; Liver; Male; Mice; Mycotoxicosis; Oligospermia; Organ Specificity; Oxidative Stress; Random Allocation; Superoxide Dismutase; Testis; Up-Regulation; Zearalenone | 2012 |
Characterization of fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Corneal Ulcer; Disease Models, Animal; Disease Outbreaks; Drug Resistance, Fungal; Epithelium, Corneal; Eye Infections, Fungal; Fusariosis; Fusarium; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microscopy, Confocal; Natamycin; Pyrimidines; Triazoles; Virulence; Voriconazole | 2012 |
Selective sequestration of STAT1 in the cytoplasm via phosphorylated SHP-2 ameliorates murine experimental colitis.
Topics: Animals; Cells, Cultured; Cerebrosides; Colitis; Cytosol; Disease Models, Animal; Fusarium; Immunosuppressive Agents; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, SCID; Mice, Transgenic; Phosphorylation; Protein Binding; Protein Transport; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Signal Transduction; STAT1 Transcription Factor; Th1 Cells | 2012 |
Improving the mouse model for studying the efficacy of voriconazole.
Topics: Animals; Beverages; Citrus paradisi; Disease Models, Animal; Fusarium; Kidney; Mice; Mice, Inbred ICR; Mycoses; Pyrimidines; Spleen; Triazoles; Voriconazole | 2003 |
Experimental murine hyalohyphomycosis with soil-derived isolates of Fusarium solani.
Topics: Animals; Colony Count, Microbial; Cyclosporine; Cyclosporins; Disease Models, Animal; Fusarium; Injections, Intravenous; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Mycoses; Renal Insufficiency; Soil Microbiology; Survival Analysis; Virulence | 2003 |
Immunosuppression affects the severity of experimental Fusarium solani keratitis.
Topics: Animals; Cornea; Cyclophosphamide; Disease Models, Animal; Eye Infections, Fungal; Female; Fusarium; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Keratitis; Mice; Mice, Inbred BALB C; Severity of Illness Index; Virulence | 2004 |
Pentamidine is active in a neutropenic murine model of acute invasive pulmonary fusariosis.
Topics: Animals; Antifungal Agents; Disease Models, Animal; Fusarium; Lung Diseases, Fungal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Neutropenia; Opportunistic Infections; Pentamidine | 2006 |
Therapeutic effectiveness of orally administered transgenic low-alkaloid tobacco expressing human interleukin-10 in a mouse model of colitis.
Topics: Animals; Colitis; Disease Models, Animal; Expressed Sequence Tags; Fusarium; Humans; Interleukin-10; Mice; Nicotiana; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Plant Diseases; Plants, Genetically Modified; Transcription, Genetic; Triticum | 2007 |
Expression of matrix metalloproteinases 2 and 9 in experimental corneal injury and fungal keratitis.
Topics: Animals; Corneal Injuries; Corneal Ulcer; Cyclophosphamide; Disease Models, Animal; Eye Infections, Fungal; Eye Injuries; Female; Fusarium; Immunosuppressive Agents; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mycoses; Wounds, Nonpenetrating | 2007 |
Efficacy of topical caspofungin in experimental fusarium keratitis.
Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Caspofungin; Corneal Ulcer; Disease Models, Animal; Echinocandins; Eye Infections, Fungal; Fusarium; Lipopeptides; Mycoses; Peptides, Cyclic; Rabbits; Treatment Outcome | 2007 |
Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis.
Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Corneal Ulcer; Disease Models, Animal; Eye Infections, Fungal; Fusarium; Itraconazole; Mycoses; Pyrimidines; Rabbits; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Polyhexamethylene biguanide (PHMB) in the treatment of experimental Fusarium keratomycosis.
Topics: Administration, Topical; Animals; Biguanides; Colony Count, Microbial; Cornea; Disease Models, Animal; Disinfectants; Eye Infections, Fungal; Fusarium; Keratitis; Ophthalmic Solutions; Rabbits; Treatment Outcome | 1997 |
Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Disease Models, Animal; Fusarium; Guinea Pigs; Itraconazole; Mice; Microbial Sensitivity Tests; Mycetoma; Pseudallescheria; Statistics as Topic; Treatment Outcome | 1998 |
The anti-inflammatory effect of fusafungine during experimentally induced rhinosinusitis in the rabbit.
Topics: Administration, Intranasal; Aerosols; Animals; Anti-Bacterial Agents; Depsipeptides; Disease Models, Animal; Female; Fusarium; Male; Maxillary Sinusitis; Nasal Mucosa; Pneumococcal Infections; Rabbits; Rhinitis | 1998 |
Experimental pathogenicity of four opportunist Fusarium species in a murine model.
Topics: Animals; Disease Models, Animal; Fusarium; Heart; Humans; Immunocompetence; Kidney; Male; Mice; Mycoses; Myocardium; Opportunistic Infections; Virulence | 1999 |
An animal model of Fusarium solani endophthalmitis.
Topics: Animals; Disease Models, Animal; Endophthalmitis; Eye; Fusarium; Mycoses; Rats | 1979 |
Laboratory isolation techniques in human and experimental fungal infections.
Topics: Animals; Anterior Chamber; Bacteriological Techniques; Corneal Diseases; Disease Models, Animal; Endophthalmitis; Eye Diseases; Fungi; Fusarium; Humans; Mycoses; Rats; Vitreous Body | 1979 |
[Experimental fungal keratitis due to fusarium--improvement of inoculation technique and re-examination of animal model (author's transl)].
Topics: Animals; Disease Models, Animal; Fusarium; Keratitis; Methods; Mycoses; Rabbits | 1978 |
Animal model of Fusarium solani keratitis.
Topics: Animals; Anti-Bacterial Agents; Aspergillus fumigatus; Bacteriological Techniques; Cornea; Culture Techniques; Disease Models, Animal; Fusarium; Haplorhini; Keratitis; Mycoses; Ointments; Prednisolone; Rabbits; Triamcinolone | 1975 |
Platelet aggregation in rats made hyperuricaemic with nucleic adid-rich diets containing oxonate, and inhibitor of uricase [proceedings].
Topics: Animals; Diet; Disease Models, Animal; Female; Fusarium; Gout; Nucleic Acids; Oxonic Acid; Platelet Aggregation; Rats; Triazines; Urate Oxidase; Uric Acid | 1976 |
Lack of activity of amphotericin B in systemic murine fusarial infection.
Topics: Amphotericin B; Animals; Disease Models, Animal; Drug Tolerance; Fusarium; Male; Mice; Microbial Sensitivity Tests; Mycoses | 1992 |
Influence of corticosteroid on experimentally induced keratomycosis.
Topics: Animals; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Eye Infections, Fungal; Fusarium; Keratitis; Rabbits; Triamcinolone Acetonide | 1991 |
Experimental fusarial hyalohyphomycosis in a murine model.
Topics: Animals; Cyclophosphamide; Disease Models, Animal; Fusarium; Immunosuppression Therapy; Male; Mice; Mycoses; Neutropenia | 1991 |
Excimer laser ablative treatment of microbial keratitis.
Topics: Animals; Cornea; Disease Models, Animal; Eye Infections, Bacterial; Eye Infections, Fungal; Fusarium; Keratitis; Laser Therapy; Male; Mycobacterium; Mycobacterium Infections, Nontuberculous; Rabbits | 1991 |
Fusarium and the immunocompromised host: liaisons dangeureuses.
Topics: Animals; Disease Models, Animal; Fusarium; Humans; Immune Tolerance; Mice; Mycoses; Rabbits; Risk Factors | 1990 |
Severe oral lesions in chickens caused by ingestion of dietary fusariotoxin T-2.
Topics: Analysis of Variance; Animal Feed; Animals; Bacteriological Techniques; Body Weight; Chickens; Disease Models, Animal; Dose-Response Relationship, Drug; Escherichia coli; Food Microbiology; Fungi; Fusarium; Male; Mouth; Mouth Diseases; Mycotoxins; Poultry Diseases; Staphylococcus; Zea mays | 1972 |